Benitec Biopharma Capital Expenditures (CapEx) Growth & History (BNTC)

Benitec Biopharma's capital expenditures (capex) was $18,000 for fiscal 2025.

View full Benitec Biopharma company overview

Benitec Biopharma annual capital expenditures (capex) history

Benitec Biopharma annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-06-30$18,000−$161,000−89.94%
20242024-06-30$179,000$178,000+17800.00%
20232023-06-30$1,000−$12,000−92.31%
20222022-06-30$13,000−$208,000−94.12%
20212021-06-30$221,000$126,000+132.63%
20202020-06-30$95,000−$309,000−76.49%
20192019-06-30$404,000

Benitec Biopharma capital expenditures (capex) trends

Over the last five fiscal years, Benitec Biopharma's capital expenditures (capex) decreased from $95,000 to $18,000, a change of −$77,000. The latest reported quarter, Q3 2026, shows $15,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Benitec Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about BNTC yet. Start the conversation.

Write the first post